BioXcel Therapeutics Inc

NASDAQ:BTAI   3:59:55 PM EDT
13.51
-0.06 (-0.44%)
Earnings Announcements

Bioxcel Therapeutics Reports Q1 Results And Recent Operational Highlights

Published: 05/09/2022 13:45 GMT
BioXcel Therapeutics Inc (BTAI) - Bioxcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights.
Qtrly Net Loss per Share $1.12.
Q1 Earnings per Share View $-1.15 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.22

Next Quarter Revenue Guidance is expected to be $3.08 Million
Next Quarter EPS Guidance is expected to be -$1.23

More details on our Analysts Page.